Lv4
676 积分 2023-07-17 加入
Stakeholders of Theranostics
1天前
求助中
MIRD Monograph: Radiobiology and Dosimetry for Radiopharmaceutical Therapy with Alpha-Particle Emitters
3天前
已完结
Multicycle Dosimetric Behavior and Dose–Effect Relationships in [177Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy
4天前
求助中
Stakeholders of Theranostics
6天前
已关闭
Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer
9天前
已完结
An 211At-labeled Tetrazine for Pretargeted Therapy
11天前
已完结
FDA Reconsiders Rules Around Radiation Dosimetry for First-in-Human Studies of Investigational PET Radiopharmaceuticals
13天前
已关闭
Patient-Specific Dosimetry-Driven PRRT: Time to Move Forward!
17天前
已完结
Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG)
17天前
已完结
Tumor Dose–Response Relationship of [131I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [124I]MIBG PET
20天前
已关闭
皖公网安备34019202002308
